CABOMETYX (Exelixis, Inc.)
Welcome to the PulseAid listing for the CABOMETYX drug offered from Exelixis, Inc.. This Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Exelixis, Inc. |
| NON-PROPRIETARY NAME: | cabozantinib |
| SUBSTANCE NAME: | CABOZANTINIB S-MALATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2016-04-25 |
| END MARKETING DATE: | 0000-00-00 |
CABOMETYX HUMAN PRESCRIPTION DRUG Details:
| Item Description | CABOMETYX from Exelixis, Inc. |
| LABELER NAME: | Exelixis, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 60(mg/1) |
| START MARKETING DATE: | 2016-04-25 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 42388-023_6e822a08-5696-432d-bb8c-a53a0ceaaefa |
| PRODUCT NDC: | 42388-023 |
| APPLICATION NUMBER: | NDA208692 |
Other CABOZANTINIB S-MALATE Pharmaceutical Manufacturers / Labelers:
